HITIQ Appoints High-Profile Advisory Board

ASX Summary (for release)

HITIQ Limited (ASX: HIQ) has appointed three high-profile advisors to a newly formed Advisory Board to strengthen the Company’s product development, market positioning, athlete engagement and commercial expansion for the PROTEQT™ platform. The Advisory Board will also support market education and endorsement initiatives across their respective networks.

Appointments include Dr Martin Lang (former NRL player and neuroscientist specialising in contact sport–induced traumatic brain injury), Kalindi Commerford (former Hockeyroo and concussion advocate, strengthening alignment with the Hockey Australia partnership and women’s sport markets), and Richard Nash (former BrainEye CEO and MedTech executive with deep commercialisation, regulatory and partnership experience). HITIQ expects the combined athlete credibility, scientific expertise and medtech leadership to enhance PROTEQT™’s evidence-based positioning and support ongoing growth.